BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 29315497)

  • 1. Health care disparities among octogenarians and nonagenarians with stage III lung cancer.
    Cassidy RJ; Zhang X; Switchenko JM; Patel PR; Shelton JW; Tian S; Nanda RH; Steuer CE; Pillai RN; Owonikoko TK; Ramalingam SS; Fernandez FG; Force SD; Gillespie TW; Curran WJ; Higgins KA
    Cancer; 2018 Feb; 124(4):775-784. PubMed ID: 29315497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health care disparities among octogenarians and nonagenarians with stage II and III rectal cancer.
    Cassidy RJ; Switchenko JM; Cheng E; Jiang R; Jhaveri J; Patel KR; Tanenbaum DG; Russell MC; Steuer CE; Gillespie TW; McDonald MW; Landry JC
    Cancer; 2017 Nov; 123(22):4325-4336. PubMed ID: 28759121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of conformal radiotherapy technique on survival after chemoradiotherapy for patients with stage III non-small cell lung cancer in the National Cancer Data Base.
    Sher DJ; Koshy M; Liptay MJ; Fidler MJ
    Cancer; 2014 Jul; 120(13):2060-8. PubMed ID: 24692108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Chemoradiotherapy in Elderly Patients With Limited-Stage Small-Cell Lung Cancer.
    Corso CD; Rutter CE; Park HS; Lester-Coll NH; Kim AW; Wilson LD; Husain ZA; Lilenbaum RC; Yu JB; Decker RH
    J Clin Oncol; 2015 Dec; 33(36):4240-6. PubMed ID: 26481366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guideline-concordant Care Improves Overall Survival for Locally Advanced Non-Small-cell Lung Carcinoma Patients: A National Cancer Database Analysis.
    Ahmed HZ; Liu Y; O'Connell K; Ahmed MZ; Cassidy RJ; Gillespie TW; Patel P; Pillai RN; Behera M; Steuer CE; Owonikoko TK; Ramalingam SS; Curran WJ; Higgins KA
    Clin Lung Cancer; 2017 Nov; 18(6):706-718. PubMed ID: 28601387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent Versus Sequential Chemoradiation Therapy in Completely Resected Pathologic N2 Non-Small Cell Lung Cancer: Propensity-Matched Analysis of the National Cancer Data Base.
    Moreno AC; Haque W; Verma V; Fang P; Lin SH
    Ann Surg Oncol; 2018 May; 25(5):1245-1253. PubMed ID: 29484562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with treatment receipt and overall survival for patients with locally advanced large cell neuroendocrine carcinoma of the lung: A National Cancer Database analysis.
    Limonnik V; Abel S; Finley GG; Long GS; Wegner RE
    Lung Cancer; 2020 Dec; 150():107-113. PubMed ID: 33126090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes of black vs. non-black patients with locally advanced non-small cell lung cancer.
    Vyfhuis MAL; Bhooshan N; Molitoris J; Bentzen SM; Feliciano J; Edelman M; Burrows WM; Nichols EM; Suntharalingam M; Donahue J; Nagib M; Carr SR; Friedberg J; Badiyan S; Simone CB; Feigenberg SJ; Mohindra P
    Lung Cancer; 2017 Dec; 114():44-49. PubMed ID: 29173764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role for Surgical Resection in the Multidisciplinary Treatment of Stage IIIB Non-Small Cell Lung Cancer.
    Bott MJ; Patel AP; Crabtree TD; Morgensztern D; Robinson CG; Colditz GA; Waqar S; Kreisel D; Krupnicka AS; Patterson GA; Broderick S; Meyers BF; Puri V
    Ann Thorac Surg; 2015 Jun; 99(6):1921-8. PubMed ID: 25912748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Socioeconomic disparities in lung cancer treatment and outcomes persist within a single academic medical center.
    Yorio JT; Yan J; Xie Y; Gerber DE
    Clin Lung Cancer; 2012 Nov; 13(6):448-57. PubMed ID: 22512997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Radiation Dose to the Host Immune System on Tumor Control and Survival for Stage III Non-Small Cell Lung Cancer Treated with Definitive Radiation Therapy.
    Ladbury CJ; Rusthoven CG; Camidge DR; Kavanagh BD; Nath SK
    Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):346-355. PubMed ID: 31175902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variations in Initiation Dates of Chemotherapy and Radiation Therapy for Definitive Management of Inoperable Non-Small Cell Lung Cancer Are Associated With Decreases in Overall Survival.
    Deek MP; Kim S; Beck R; Yegya-Raman N; Langenfeld J; Malhotra J; Mahmoud O; Aisner J; Jabbour SK
    Clin Lung Cancer; 2018 Jul; 19(4):e381-e390. PubMed ID: 29752011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of survival outcomes among standard radiotherapy regimens in limited-stage small cell lung cancer patients receiving concurrent chemoradiation.
    Rutter CE; Park HS; Corso CD; Yeboa DN; Mancini BR; Lester-Coll NH; Kim AW; Decker RH
    Lung Cancer; 2015 Nov; 90(2):243-8. PubMed ID: 26277031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effectiveness of neoadjuvant chemoradiotherapy versus chemotherapy alone followed by surgery for patients with stage IIIA non-small cell lung cancer.
    Sher DJ; Fidler MJ; Liptay MJ; Koshy M
    Lung Cancer; 2015 Jun; 88(3):267-74. PubMed ID: 25862147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant chemoradiation and surgery improves survival outcomes compared with definitive chemoradiation in the treatment of stage IIIA N2 non-small-cell lung cancer.
    Darling GE; Li F; Patsios D; Massey C; Wallis AG; Coate L; Keshavjee S; Pierre A; De Perrot M; Yasufuku K; Cypel M; Waddell T
    Eur J Cardiothorac Surg; 2015 Nov; 48(5):684-90; discussion 690. PubMed ID: 25567960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival outcomes and predicting intracranial metastasis in stage III non-small cell lung cancer treated with definitive chemoradiation: Real-world data from a tertiary cancer center.
    Thibodeau S; Meem M; Hopman W; Sandhu S; Zalay O; Fung AS; Kartolo A; Digby GC; Al-Ghamdi S; Robinson A; Ashworth A; Owen T; Mahmud A; Tam K; Olding T; de Moraes FY
    Cancer Treat Res Commun; 2023; 36():100747. PubMed ID: 37531737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of treatment and survival among older patients with stage III non-small cell lung cancer.
    Driessen EJM; Schulkes KJG; Dingemans AC; van Loon JGM; Hamaker ME; Aarts MJ; Janssen-Heijnen MLG
    Lung Cancer; 2018 Feb; 116():55-61. PubMed ID: 29413051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of care in hilar node-positive (N1) non-small cell lung cancer: A missed treatment opportunity?
    Bott MJ; Patel AP; Verma V; Crabtree TD; Morgensztern D; Robinson CG; Colditz GA; Waqar S; Kreisel D; Krupnick AS; Patterson GA; Broderick S; Meyers BF; Puri V
    J Thorac Cardiovasc Surg; 2016 Jun; 151(6):1549-1558.e2. PubMed ID: 27207124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy and Radiation Versus Chemotherapy Alone for Elderly Patients With N3 Stage IIIB NSCLC.
    Qin A; Lusk E; Daignault-Newton S; Schneider BJ
    Clin Lung Cancer; 2019 Jul; 20(4):e495-e503. PubMed ID: 31088760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Survival Rates After a Combination of Local Treatment and Systemic Therapy vs Systemic Therapy Alone for Treatment of Stage IV Non-Small Cell Lung Cancer.
    Uhlig J; Case MD; Blasberg JD; Boffa DJ; Chiang A; Gettinger SN; Kim HS
    JAMA Netw Open; 2019 Aug; 2(8):e199702. PubMed ID: 31433481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.